Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Author:

Eisen Alon12,Bhatt Deepak L.12,Steg P. Gabriel3456,Eagle Kim A.7,Goto Shinya8,Guo Jianping12,Smith Sidney C.9,Ohman E. Magnus10,Scirica Benjamin M.12,

Affiliation:

1. Brigham and Women's Hospital, Boston, MA

2. Harvard Medical School, Boston, MA

3. Département Hospitalo‐Universitaire FIRE (Fibrosis, Inflammation, Remodeling), Université Paris‐Diderot, Sorbonne Paris Cité, Paris, France

4. FACT (French Alliance for Cardiovascular Clinical Trials), Hôpital Bichat, Assistance Publique‐Hôpitaux de Paris, Paris, France

5. INSERM U‐1148, Paris, France

6. National Heart and Lung Institute, Royal Brompton Hospital, Imperial College, London, United Kingdom

7. University of Michigan Health System, Ann Arbor, MI

8. Department of Medicine, Tokai University School of Medicine, Isehara, Japan

9. Heart and Vascular Center, University of North Carolina at Chapel Hill, NC

10. Duke University Medical Center, Durham, NC

Abstract

Background The extent to which angina is associated with future cardiovascular events in patients with coronary artery disease has long been debated. Methods and Results Included were outpatients with established coronary artery disease who were enrolled in the REACH registry and were followed for 4 years. Angina at baseline was defined as necessitating episodic or permanent antianginal treatment. The primary end point was the composite of cardiovascular death, myocardial infarction, or stroke. Secondary end points included heart failure, cardiovascular hospitalizations, and coronary revascularization. The independent association between angina and first/total events was examined using Cox and logistic regression models. Out of 26 159 patients with established coronary artery disease, 13 619 (52%) had angina at baseline. Compared with patients without angina, patients with angina were more likely to be older, female, and had more heart failure and polyvascular disease ( P <0.001 for each). Compared with patients without angina, patients with angina had higher rates of first primary end‐point event (14.2% versus 16.3%, unadjusted hazard ratio 1.19, CI 1.11–1.27, P <0.001; adjusted hazard ratio 1.06, CI 0.99–1.14, P =0.11), and total primary end‐point events (adjusted risk ratio 1.08, CI 1.01–1.16, P =0.03). Patients with angina were at increased risk for heart failure (adjusted odds ratio 1.17, CI 1.06–1.28, P =0.002), cardiovascular hospitalizations (adjusted odds ratio 1.29, CI 1.21–1.38, P <0.001), and coronary revascularization (adjusted odds ratio 1.23, CI 1.13–1.34, P <0.001). Conclusions Patients with stable coronary artery disease and angina have higher rates of future cardiovascular events compared with patients without angina. After adjustment, angina was only weakly associated with cardiovascular death, myocardial infarction, or stroke, but significantly associated with heart failure, cardiovascular hospitalization, and coronary revascularization.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3